Incidence of new outpatient long-acting reversible contraceptive insertions among a commercially insured, US population from 2010 to 2020

Incidence of new outpatient long-acting reversible contraceptive insertions among a commercially insured, US population from 2010 to 2020

Objectives: Characterize new use of long-acting reversible contraceptives (LARCs), highly effective contraceptive methods, in a broad population over time. Study Design: We constructed a retrospective cohort of commercially insured individuals aged 15 to 54 years from 2010 to 2020 and estimated mont...

Full description

Bibliographic Details
Main Authors: Clara E. Busse, Chase D. Latour, Sara Z. Dejene, Andrea K. Knittel, Mollie E. Wood, Alan C. Kinlaw, Mekhala V. Dissanayake
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:Contraception: X
Subjects:
Contraception
Family planning
Hormonal implants
Insurance claims
Intrauterine devices
Long-acting reversible contraceptives
Online Access:http://www.sciencedirect.com/science/article/pii/S2590151623000138

Internet

http://www.sciencedirect.com/science/article/pii/S2590151623000138

Similar Items